by Heather Mayer
, DOTmed News Reporter | September 21, 2010
Cardiac Science Corp. began shipping the Quinton Q-Stress cardiac stress systems with Cambridge Heart Inc.'s microvolt T-wave alternans modules Tuesday. DOTmed News reported in June
that Cambridge Heart received FDA approval to sell the MTWA modules with systems other than their own.
The MTWA is a noninvasive test that detects the risk for sudden cardiac arrest.
Last November, Cambridge Heart announced the integration of its MTWA module with Cardiac Science.
Numed, a well established company in business since 1975 provides a wide range of service options including time & material service, PM only contracts, full service contracts, labor only contracts & system relocation. Call 800 96 Numed for more info.
"The partnership with Cardiac Science...allows our technology to be marketed to a much broader number of cardiologists and internal medicine practices," said Ali Haghighi-Mood president and CEO of Cambridge Heart, in prepared remarks.
The module integrates with both new and existing cardiac stress testing systems and cardiac monitoring systems, the company said. Cambridge Heart's MTWA test is the only one of its kind to be reimbursed through Medicare.